FindTrial
Sign In

Value of virtual Touch Tissue Quantification combined with BRAFV600E in predicting central lymph nodes metastasis of thyroid carcinoma and Related Pathological Analysis

Value of virtual Touch Tissue Quantification combined with BRAFV600E in predicting central lymph nodes metastasis of thyroid carcinoma and Related Pathological Analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200067125
Enrollment
Unknown
Registered
2022-12-27
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid nodules

Interventions

Gold Standard:Postoperative pathological results
Index test:Virtual touch tissue quantification

Sponsors

China-Japan Friendship Hospita
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Patients planning thyroid nodule surgery; ? The patient understands this content and voluntarily participates and signs the informed consent form; ? The patient can cooperate to complete VTQ examination.

Exclusion criteria

Exclusion criteria: ? History of head and neck radiotherapy; ? History of radiofrequency or cryotherapy for nodules; ? No pathological results or unclear results; ? Patients cannot cooperate with VTQ examination.

Design outcomes

Primary

MeasureTime frame
shear wave velocity;Fiber area percentage;BRAF gene;—

Secondary

MeasureTime frame
Gray scale and color information of thyroid nodule;Gray scale and color data of peripheral lymph nodes;—

Countries

China

Contacts

Public ContactJingping Wu

China-Japan Friendship Hospital

1098183571@qq.com84205417/5419

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026